Retail & Wholesale » Retail | China NT Pharma Group Co. Ltd.

China NT Pharma Group Co. Ltd. | Cash Flow

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
823,701.30
21,806.50
124,217.70
41,529.10
261,091.20
665,661.90
Depreciation, Depletion & Amortization
34,169.90
28,744.80
19,248.50
26,323.30
38,548.80
41,048.40
Other Funds
185,472.60
-
47,730.80
145,198.20
-
689,615.10
Funds from Operations
223,471.70
9,422.60
134,951.40
223,159.80
234,763.90
65,001.60
Changes in Working Capital
135,676.30
50,906.30
505,907.20
227,130.00
111,144.90
282,744.50
Net Operating Cash Flow
87,795.40
60,328.90
370,955.70
3,970.30
123,619.00
217,742.90
Capital Expenditures
22,858.50
148,748.10
51,791.40
846,172.20
399,703.70
Sale of Fixed Assets & Businesses
42,945.10
329.70
1,694.80
508.30
4,233.00
Purchase/Sale of Investments
20,187.50
16,360.90
6,167.40
14,021.00
47,564.80
Net Investing Cash Flow
170,432.90
99,844.20
146,618.90
870,800.10
362,896.00
Cash Dividends Paid - Total
-
-
-
15,480.40
39,151.90
Issuance/Reduction of Debt, Net
59,978.30
43,801.90
467,601.40
877,808.30
296,895.70
Net Financing Cash Flow
245,450.90
43,801.90
262,550.10
711,014.20
221,435.30
Net Change in Cash
15,362.70
85,217.50
253,640.60
150,445.60
12,206.60
Free Cash Flow
98,297.90
171,818.20
417,823.10
17,936.40
112,394.80
Net Assets from Acquisitions
-
-
90,354.90
11,115.20
14,990.10
Other Sources
-
231,901.70
-
-
-
Change in Capital Stock
-
-
682,420.70
6,115.50
36,308.40
Exchange Rate Effect
2,585.30
1,900.40
1,384.00
13,310.60
5,635.10
Other Uses
170,332.00
-
-
-
-

About China NT Pharma Group Co.

View Profile
Address
Unit 1505, 15th Floor
Hong Kong
Hong Kong
Employees -
Website http://www.ntpharma.com
Updated 07/08/2019
China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the provision of distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. It operates through the following segments: Proprietary Products Production and Sales, and Miacalcic. The Proprietary Products Production and Sales segment engages in the production and sales of the company branded products and generic drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.